Cargando…
Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease
INTRODUCTION: Maintenance treatment strategies in COPD recommend inhaled corticosteroid (ICS) + long-acting muscarinic antagonist (LAMA) + long-acting β(2)-agonist (LABA) triple therapy after initial dual therapy. Little is known about how treatment pathways to triple therapy vary across countries i...
Autores principales: | Quint, Jennifer K., O’Leary, Caroline, Venerus, Alessandra, Myland, Melissa, Holmgren, Ulf, Varghese, Precil, Richter, Hartmut, Bizouard, Geoffray, Cabrera, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672143/ https://www.ncbi.nlm.nih.gov/pubmed/33064273 http://dx.doi.org/10.1007/s41030-020-00132-7 |
Ejemplares similares
-
Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK
por: Quint, Jennifer K, et al.
Publicado: (2020) -
Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study
por: Quint, Jennifer K., et al.
Publicado: (2020) -
Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States
por: Schabert, Vernon, et al.
Publicado: (2021) -
Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study
por: Jude, Edward B., et al.
Publicado: (2019) -
Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN)
por: Jude, Edward B., et al.
Publicado: (2019)